68 related articles for article (PubMed ID: 29544131)
1. Similar incidence of typhlitis in patients receiving various doses of daunorubicin or idarubicin as induction for acute myeloid leukemia.
Seddon AN; Chaim J; Akin O; Drill E; Michael AG; Adel N; Tallman MS
Leuk Res; 2018 May; 68():48-50. PubMed ID: 29544131
[TBL] [Abstract][Full Text] [Related]
2. Midostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trial.
Sierra J; Montesinos P; Thomas X; Griskevicius L; Cluzeau T; Caillot D; Legrand O; Minotti C; Luppi M; Farkas F; Bengoudifa BR; Gilotti G; Hodzic S; Rambaldi A; Venditti A
Blood Adv; 2023 Nov; 7(21):6441-6450. PubMed ID: 37581981
[TBL] [Abstract][Full Text] [Related]
3. Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML.
Lancet JE; Cortes JE; Hogge DE; Tallman MS; Kovacsovics TJ; Damon LE; Komrokji R; Solomon SR; Kolitz JE; Cooper M; Yeager AM; Louie AC; Feldman EJ
Blood; 2014 May; 123(21):3239-46. PubMed ID: 24687088
[TBL] [Abstract][Full Text] [Related]
4. Chloroquine enhances the efficacy of chemotherapy drugs against acute myeloid leukemia by inactivating the autophagy pathway.
Wang HL; Li JN; Kan WJ; Xu GY; Luo GH; Song N; Wu WB; Feng B; Fu JF; Tu YT; Liu MM; Xu R; Zhou YB; Wei G; Li J
Acta Pharmacol Sin; 2023 Nov; 44(11):2296-2306. PubMed ID: 37316630
[TBL] [Abstract][Full Text] [Related]
5. Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis.
Foran JM; Sun Z; Lai C; Fernandez HF; Cripe LD; Ketterling RP; Racevskis J; Luger SM; Paietta E; Lazarus HM; Zhang Y; Bennett JM; Levine RL; Rowe JM; Litzow MR; Tallman MS
Cancer; 2023 Aug; 129(16):2479-2490. PubMed ID: 37185873
[TBL] [Abstract][Full Text] [Related]
6. Bewersdorf JP, Patel KK, Goshua G, et al. Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia. Blood. 2022;139(11):1766-1770.
Blood; 2023 Apr; 141(14):1778. PubMed ID: 37022730
[No Abstract] [Full Text] [Related]
7. Impact of different chemotherapy regimens on intestinal mucosal injury assessed with bedside ultrasound: a study in 213 AML patients.
Benedetti E; Traverso G; Pucci G; Morganti R; Bramanti E; Lippolis P; Susini MC; Mazzantini E; Giubbolini R; Mavilia F; Capochiani E; Neri E; Arena C; Cerri F; De Simone L; Valentini K; Stella SM; Ricchiuto V; Bruno B; Galimberti S
Front Oncol; 2023; 13():1272072. PubMed ID: 38023169
[TBL] [Abstract][Full Text] [Related]
8. Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia.
Stahl M; Giblin G; Liu Y; Winer ES; Garcia JS; Chen E; Wadleigh M; Ling K; Lindsley RC; Shimony S; Copson K; Charles A; DeAngelo DJ; Stone RM; Nohria A; Luskin MR
Leuk Res; 2023 Sep; 132():107351. PubMed ID: 37451200
[TBL] [Abstract][Full Text] [Related]
9. Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review.
Chang Y; Guyatt GH; Teich T; Dawdy JL; Shahid S; Altman JK; Stone RM; Sekeres MA; Mukherjee S; LeBlanc TW; Abel GA; Hourigan CS; Litzow MR; Michaelis LC; Alibhai SMH; Desai P; Buckstein R; MacEachern J; Brignardello-Petersen R
PLoS One; 2021; 16(3):e0249087. PubMed ID: 33784346
[TBL] [Abstract][Full Text] [Related]
10. Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients.
Qiao X; van der Zanden SY; Li X; Tan M; Zhang Y; Song JY; van Gelder MA; Hamoen FL; Janssen L; Zuur CL; Pang B; van Tellingen O; Li J; Neefjes J
Mol Cancer; 2024 Jun; 23(1):120. PubMed ID: 38831402
[TBL] [Abstract][Full Text] [Related]
11. Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia.
Vachhani P; Shin S; Baron J; Thompson JE; Wetzler M; Griffiths EA; Ontiveros EP; Spangenthal EJ; Wang ES
Leuk Res Rep; 2017; 7():36-39. PubMed ID: 28462084
[TBL] [Abstract][Full Text] [Related]
12. Dosing of 7 + 3 induction chemotherapy in a patient with acute myeloid leukemia (AML) and morbid obesity.
Franco S; Khan T; Dinner S; Karmali R; Melody M
J Oncol Pharm Pract; 2024 Mar; ():10781552241240444. PubMed ID: 38509800
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial.
Liebers N; Bruch PM; Terzer T; Hernandez-Hernandez M; Paramasivam N; Fitzgerald D; Altmann H; Roider T; Kolb C; Knoll M; Lenze A; Platzbecker U; Röllig C; Baldus C; Serve H; Bornhäuser M; Hübschmann D; Müller-Tidow C; Stölzel F; Huber W; Benner A; Zenz T; Lu J; Dietrich S
Nat Cancer; 2023 Dec; 4(12):1648-1659. PubMed ID: 37783805
[TBL] [Abstract][Full Text] [Related]
14. Quizartinib (Vanflyta) for acute myeloid leukemia.
Med Lett Drugs Ther; 2023 Oct; 65(1687):e169-e170. PubMed ID: 37871118
[No Abstract] [Full Text] [Related]
15. Demographic and clinical characteristics of acute myeloid leukaemia diagnosed and treated at the tertiary level in Afghanistan.
Noor S; Haidary AM; Yosufzai AW; Niazai M; Noor S; Nasir N; Shinwari A; Saadaat R
Br J Haematol; 2023 Nov; 203(3):404-410. PubMed ID: 37609793
[TBL] [Abstract][Full Text] [Related]
16. Typhlitis.
Hudson AT
Chic Med J; 1867; 24(4-5):159-161. PubMed ID: 37412993
[No Abstract] [Full Text] [Related]
17. A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia.
Redner RL; Beumer JH; Kropf P; Agha M; Boyiadzis M; Dorritie K; Farah R; Hou JZ; Im A; Lim SH; Raptis A; Sehgal A; Christner SM; Normolle D; Johnson DE
Leuk Lymphoma; 2018 Nov; 59(11):2595-2601. PubMed ID: 29616864
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma.
Hassan Zafar MS; Khan AA; Aggarwal S; Bhargava M
South Asian J Cancer; 2018; 7(1):58-60. PubMed ID: 29600238
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]